FDA approval of the first RNAi drug
CureFFI.org,
The headquarters of Alnylam, a few blocks from our lab in Cambridge, MA. Late Friday afternoon, FDA announced the approval of…
Antisense part II: mechanisms of action
CureFFI.org,
This post is second in a series of posts on the science of antisense oligonucleotides as therapeutics. In my last post in this…
Striking the Heart of Hydra with miRNA
Mission Tumor,
Cancer has long been depicted as a nasty crab. Now Colin Barras describes it as a “distant animal ancestor, a ‘living fossil…